GlassScriptPhysician profile
Charles A Caplis
NPI 1841483666
$9,176.09
in general payments reported to CMS, 2019-2025
43 companies · $1,294 in 2025
The $1,294 reported for 2025 was more than what 89% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,483 · 2020: $941 · 2021: $1,238 · 2022: $1,879 · 2023: $1,501 · 2024: $838 · 2025: $1,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,734 · Debt Forgiveness: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,733.70 |
| Debt Forgiveness | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,942.35 | 2019-2025 | Puraply, Affinity, Apligraf |
| Horizon Therapeutics Plc | $1,333.14 | 2019-2023 | Krystexxa |
| Convatec INC. | $985.33 | 2023-2025 | |
| Paratek Pharmaceuticals, INC. | $394.33 | 2019-2025 | Nuzyra |
| Stryker Corporation | $393.99 | 2019-2024 | Prophecy, Ortholoc 2 Lapifuse |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $346.44 | 2019-2024 | Jublia |
| Wright Medical Technology, INC. | $343.30 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $310.82 | 2022-2023 | Seglentis |
| Journey Medical Corporation | $228.05 | 2019-2021 | |
| Smith+Nephew, INC. | $216.49 | 2019-2023 | Regranex, Collagenase Santyl |
| Nevro Corp. | $172.67 | 2022-2023 | Senza |
| Advanced Medical Administration | $156.02 | 2025 | Amniograft |
| Arthrosurface Incorporated | $134.63 | 2020 | |
| Treace Medical Concepts, INC. | $130.83 | 2022-2025 | |
| Musculoskeletal Transplant Foundation INC. | $111.33 | 2020-2021 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $102.96 | 2022-2025 | Cmf |
| Paragon 28, INC. | $82.33 | 2021-2022 | |
| Medtronic, INC. | $68.19 | 2022-2023 | Intellis Adaptivestim |
| Kerecis Limited | $63.61 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Grt US Holding, INC. | $57.74 | 2022 | |
| Assertio Therapeutics, INC. | $47.90 | 2019 | |
| Arbor Pharmaceuticals, INC. | $42.63 | 2019 | |
| Melinta Therapeutics, LLC | $42.35 | 2019 | |
| Depuy Synthes Sales INC. | $42.14 | 2025 | Motoband |
| Misonix INC | $38.63 | 2020 | |
| Bioventus LLC | $31.63 | 2020-2021 | |
| Trilliant Surgical LLC. | $30.86 | 2024 | 3s Hemi Implant, Large, Non-Sterile |
| Kci USA, INC. | $29.11 | 2019-2020 | |
| Integra Lifesciences Corporation | $28.92 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Alon Medical Technology | $25.20 | 2024 | |
| Abbvie INC. | $25.12 | 2024 | |
| Forte Bio-Pharma LLC | $23.75 | 2019-2020 | |
| Orthofix Medical, INC. | $23.08 | 2025 | Physio-Stim |
| Zyla Life Sciences, INC. | $21.79 | 2019 | |
| Baudax Bio INC. | $20.04 | 2020 | |
| Reprise Biomedical, INC. | $19.98 | 2024 | Miro3d |
| Davol INC. | $18.71 | 2023 | Arista Ah Flexitip |
| Advanced Oxygen Therapy INC. | $17.71 | 2024 | Topical Oxygen Chamber For Extremities |
| Amgen INC. | $16.40 | 2025 | Krystexxa |
| Innovation Technologies INC | $14.63 | 2023 | Irrisept |
| Merck Sharp & Dohme LLC | $14.25 | 2019 | |
| Abbott Laboratories | $13.71 | 2019 | |
| Celularity INC. | $13.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Caplis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.